Projects overview

Sort by


Toggle all information

EPoS | Elucidating Pathways of Steatohepatitis

01-05-2015

-

31-10-2019

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-PHC-2014-two-stage
PHC-01-2014 Understanding health, ageing and disease: determinants, risk factors and pathways

ESPACE | Human Cell Atlas of the Pancreas

01-01-2020

-

30-06-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2019-Single-Stage-RTD
SC1-BHC-31-2019 Pilot actions to build the foundations of a human cell atlas

HarmonicSS | HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making

01-01-2017

-

31-12-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2016-RTD
SC1-PM-04-2016 Networking and optimising the use of population and patient cohorts at EU level

MultipleMS | Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine

01-01-2017

-

30-06-2023

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2016-RTD
SC1-PM-01-2016 Multi omics for personalised therapies addressing diseases of the immune system

GOLIATH | Beating Goliath: Generation Of NoveL, Integrated and Internationally Harmonised Approaches for Testing Metabolism Disrupting Compounds

01-01-2019

-

31-12-2024

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2018-Single-Stage-RTD
SC1-BHC-27-2018 New testing and screening methods to identify endocrine disrupting chemicals

Ageing with elegans | Validating C. elegans healthspan model for better understanding factors causing health and disease, to develop evidence based prevention, diagnostic, therapeutic and other strategies.

01-05-2015

-

31-10-2020

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-PHC-2014-two-stage
PHC-01-2014 Understanding health, ageing and disease: determinants, risk factors and pathways

REACH | REACH: Russian European Alliance for research among women, Children and adolescents impacted by HIV, TB and HCV

01-01-2019

-

30-06-2021

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2018-Single-Stage-RTD
SC1-BHC-21-2018 Research on HIV, tuberculosis (TB) and/or hepatitis C (HCV) in patients with mono-, co-infections and/or comorbidities in the context of fostering collaboration with the Russian Federation

ERGO | Breaking down the wall between human health and environmental testing of endocrine disrupters: EndocRine Guideline Optimisation

01-01-2019

-

30-06-2024

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2018-Single-Stage-RTD
SC1-BHC-27-2018 New testing and screening methods to identify endocrine disrupting chemicals

QSPainRelief | Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach.

01-01-2020

-

30-06-2025

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2019-Two-Stage-RTD
SC1-BHC-02-2019 Systems approaches for the discovery of combinatorial therapies for complex disorders

miniNO | Associative mechanisms linking a defective minipuberty to the appearance of mental and nonmental disorders: infantile NO replenishment as a new therapeutic possibility

01-01-2020

-

31-12-2025

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2019-Two-Stage-RTD
SC1-BHC-01-2019 Understanding causative mechanisms in co- and multimorbidities combining mental and non-mental disorders

HUTER | HUMAN UTERUS CELL ATLAS

01-01-2020

-

30-06-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2019-Single-Stage-RTD
SC1-BHC-31-2019 Pilot actions to build the foundations of a human cell atlas

HUGODECA | Human Gonad Developmental Cell Atlas

01-01-2020

-

30-06-2022

Show more information
EU-Programme-Call
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.1. Understanding health, wellbeing and disease
H2020-SC1-2019-Single-Stage-RTD
SC1-BHC-31-2019 Pilot actions to build the foundations of a human cell atlas
Powered by Chris Decubber BV